Evaluating the prognostic value of TP53 mutations in acute leukemia: a comprehensive retrospective study from a tertiary care hospital

Key Points

• TP53 mutations significantly impact prognosis in acute leukemia patients, pointing to potential treatment implications.
• The study indicates a high prevalence of TP53 mutations in acute myeloid leukemia and acute lymphoblastic leukemia cases.
• Retrospective analysis conducted at a tertiary care hospital provides new insights into the prognostic value of TP53 mutations.
• Findings suggest that further research is necessary to fully understand the implications of TP53 mutations in middle-aged and elderly populations.